Media Coverage
Page 7 of 7
-
-
Endpoints: A new Flagship startup looks to crack tRNA biology in search for completely new class of therapeutics
-
Fierce Biotech: Flagship unveils its next RNA bet with $50M for Alltrna to explore thousands of genetic diseases using transfer RNA
-
MedCity News: Flagship’s next genetic meds startup has $50M for transfer at a critical protein stop
-
TechCrunch: Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’